Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,8.134691442125034e-76,171.57575150300602,29665.50392743276,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.123721513776013e-73,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.075162733868422e-51,50.52368321333839,5876.332895613778,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",5.9043124490273695e-49,0,0,60
3,Oxidative phosphorylation WP623,1.0750732523454237e-31,55.02708648425684,3923.857675724132,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.3760937630021423e-29,0,0,36
4,Nonalcoholic fatty liver disease WP4396,1.4294395145137687e-27,10.617901473653147,656.3191950780318,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.3722619339332178e-25,0,0,52
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.7922594420855015e-26,53.196172248803826,3153.667796476899,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",1.376455251521665e-24,0,0,30
6,Mitochondrial CIV Assembly WP4922,2.3406731337482762e-17,42.157345971563984,1614.3526664392648,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14', 'COX20']",1.4980308055988968e-15,0,0,20
7,Mitochondrial complex III assembly WP4921,5.34696500105329e-08,31.297373358348967,524.0479652436094,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",2.933192229149233e-06,0,0,9
8,Cellular Proteostasis WP4918,4.6230132901410284e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",2.2190463792676935e-05,0,0,6
9,mRNA Processing WP411,2.704293638157443e-05,3.9865101848104683,41.9304518557661,"['SF3B5', 'DHX8', 'NCBP2', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.001153831952280509,0,0,16
10,Nucleotide Excision Repair WP4753,0.00033677621868402467,5.209193245778612,41.653187854016785,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.012932206797466548,0,0,9
11,DNA Mismatch Repair WP531,0.0007460059444389365,7.7988774555659495,56.15797732499829,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2']",0.026042389333141052,0,0,6
12,Ciliary landscape WP4352,0.0010278025137305732,2.2300380228136882,15.343402499595125,"['POM121', 'NUDC', 'NDUFA5', 'TRAF3IP1', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'EXOSC4', 'RAB14', 'MFAP1', 'RANBP10', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.03059332199402992,0,0,23
13,Translation Factors WP107,0.001035711421672888,3.859154929577465,26.522685669027535,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF1AY', 'EIF3I', 'EIF4H', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.03059332199402992,0,0,10
14,Cholesterol Biosynthesis Pathway WP197,0.001547542394876237,8.658878504672897,56.03235749479989,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.03961708530883167,0,0,5
15,Computational Model of Aerobic Glycolysis WP4629,0.001547542394876237,8.658878504672897,56.03235749479989,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.03961708530883167,0,0,5
16,Pyrimidine metabolism WP4022,0.0018392279998375519,3.051556799669596,19.2199539117744,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.044141471996101245,0,0,12
17,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.002461593532515525,7.421228304405875,44.578920359600005,"['EIF3I', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.05560305391093892,0,0,5
18,VEGFA-VEGFR2 Signaling Pathway WP3888,0.006537812056382553,1.6234349932683547,8.166125942976683,"['RPL5', 'SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'PTPN1', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'TFCP2', 'CYCS', 'RPL27', 'RPL26', 'EIF3F', 'CALR', 'ALDOA', 'EIF3D', 'PTMA']",0.13947332386949446,0,0,37
19,Proteasome Degradation WP183,0.006939852030067747,3.0211523331114205,15.016561617261459,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMA2', 'PSME1', 'PSMB10', 'PSMA7']",0.14025806208136918,0,0,9
20,Base Excision Repair WP4752,0.007888419873088977,4.156782039289055,20.128632721999967,"['POLE4', 'POLD4', 'NEIL2', 'TDG', 'POLD2', 'POLE3']",0.15145766156330834,0,0,6
21,Synaptic Vesicle Pathway WP2267,0.009697193254156607,3.0815370196813494,14.2857553734262,"['RAB3A', 'SLC32A1', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.17732010521886366,0,0,8
22,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.011136489245245847,10.374067164179104,46.65766006250415,"['ELOB', 'ELOC', 'RBX1']",0.18446552720374274,0,0,3
23,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.011136489245245847,10.374067164179104,46.65766006250415,"['IDI1', 'HMGCS1', 'PMVK']",0.18446552720374274,0,0,3
24,Glycolysis and Gluconeogenesis WP534,0.011529095450233921,2.9712143526576518,13.26017726876899,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'ALDOA', 'PFKM']",0.18446552720374274,0,0,8
25,Amyotrophic lateral sclerosis (ALS) WP2447,0.012609720480301673,3.6670885379409013,16.037231715409785,"['TOMM40', 'BAD', 'NEFL', 'BAX', 'NOS1', 'SOD1']",0.19368530657743369,0,0,6
26,DNA Repair Pathways Full Network WP4946,0.01322884074998554,2.27192337295818,9.826877228101301,"['POLE4', 'POLD4', 'RFC3', 'NEIL2', 'CENPX', 'TDG', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.19537980184594028,0,0,12
27,Photodynamic therapy-induced unfolded protein response WP3613,0.017064174885395963,3.9938892882818116,16.25822086960848,"['NARS', 'XBP1', 'DDIT3', 'CALR', 'HSP90B1']",0.2426904872589648,0,0,5
28,Dual hijack model of Vif in HIV infection WP3300,0.018222286895399134,7.779850746268656,31.159157083847862,"['ELOB', 'ELOC', 'RBX1']",0.2499056488511881,0,0,3
29,Mevalonate pathway WP3963,0.021911379970114823,20.732525629077355,79.2137795457721,"['HMGCS1', 'PMVK']",0.28752539906774166,0,0,2
30,Cori Cycle WP1946,0.022462921802167315,4.6125116713352,17.508583464057605,"['LDHA', 'TPI1', 'PGK1', 'ALDOA']",0.28752539906774166,0,0,4
31,Selenium Micronutrient Network WP15,0.032113190771439384,2.1222573536456837,7.297357304622932,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.37854970633703816,0,0,10
32,Ferroptosis WP4313,0.032306200665531734,2.8323837060974575,9.722146013860906,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.37854970633703816,0,0,6
33,Eukaryotic Transcription Initiation WP405,0.032531615388339215,3.244158878504673,11.11300535210604,"['GTF2A2', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.37854970633703816,0,0,5
34,Melanoma WP4685,0.03626390932834918,2.3092783505154637,7.6597198712333014,"['CCND1', 'BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.4095688582966496,0,0,8
35,Gastric acid production WP2596,0.04127256695830861,10.365330848089469,33.04008536926598,"['CCK', 'VIP']",0.4528190203425859,0,0,2
36,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.04385926731335315,2.5958840037418147,8.116730256762759,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.4656790869525359,0,0,6
37,Androgen receptor signaling pathway WP138,0.0448701203574058,2.0786116322701687,6.451975537334378,"['CCND1', 'SUMO1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.4656790869525359,0,0,9
38,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.06481613168298972,6.9095992544268405,18.90605073734277,"['COX8A', 'COX5A']",0.6222348641567013,0,0,2
39,Trans-sulfuration pathway WP2333,0.06481613168298972,6.9095992544268405,18.90605073734277,"['AHCY', 'GOT1']",0.6222348641567013,0,0,2
40,Peroxiredoxin 2 induced ovarian failure WP4873,0.06481613168298972,6.9095992544268405,18.90605073734277,"['STAR', 'BAX']",0.6222348641567013,0,0,2
41,Nanomaterial induced apoptosis WP2507,0.08228327492511574,3.4561567164179103,8.632053511548959,"['ENDOG', 'BAX', 'CYCS']",0.7601008891956532,0,0,3
42,NO/cGMP/PKG mediated Neuroprotection WP4008,0.08365582221129045,2.3581138487680544,5.850584809867678,"['BAD', 'NEFL', 'CYCS', 'NOS1', 'CALM2']",0.7601008891956532,0,0,5
43,7q11.23 copy number variation syndrome WP4932,0.08511546415472158,1.7976620002886419,4.428983537731204,"['ATP5PB', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.7601008891956532,0,0,9
44,Mitochondrial CII Assembly WP4920,0.08812172928231318,inf,inf,['SDHAF1'],0.7690623646456423,0,0,1
45,TCA cycle in senescence WP5050,0.09165598455444579,5.181733457595526,12.382855852306703,"['PDHA1', 'GOT1']",0.7821310681979374,0,0,2
46,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.09481879022337071,2.2553839902478665,5.313205818469621,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.791530770560312,0,0,5
47,Non-small cell lung cancer WP4255,0.0969821384204852,1.9121328602404888,4.46144280389937,"['EML4', 'CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.7923647053929003,0,0,7
48,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.10022939491365779,3.110261194029851,7.1545144506293585,"['LDHA', 'PDHA1', 'RPS6']",0.8018351593092623,0,0,3
49,DNA Replication WP466,0.1066973118443309,2.161214953271028,4.836278892487922,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'UBA52']",0.8257178187742114,0,0,5
50,Alzheimer's disease WP2059,0.10751534098622544,1.7670541785479272,3.9407459300560594,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'NOS1', 'CALM2']",0.8257178187742114,0,0,8
51,HIF1A and PPARG regulation of glycolysis WP2456,0.1210294880047599,4.145013979496738,8.75311331680791,"['LDHA', 'TPI1']",0.9078752966931452,0,0,2
52,Type 2 papillary renal cell carcinoma WP4241,0.12294144642719673,2.3043884220354807,4.830106628407195,"['SETD2', 'ELOB', 'ELOC', 'RBX1']",0.9078752966931452,0,0,4
53,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.13903163194299073,2.182908251019706,4.306995428033749,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.9998938720068727,0,0,4
54,Copper homeostasis WP3286,0.1463410774158455,1.9205607476635513,3.6909629048680723,"['CCND1', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9998938720068727,0,0,5
55,TP53 network WP1742,0.16181324482745557,2.3918628013777266,4.356329423385161,"['SUMO1', 'GADD45A', 'BAX']",0.9998938720068727,0,0,3
56,miRNA Biogenesis WP2338,0.16848471576649435,10.356610800744878,18.444194236281138,['RAN'],0.9998938720068727,0,0,1
57,Sleep regulation WP3591,0.17349814792790474,1.974656529278378,3.4587853806620767,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9998938720068727,0,0,4
58,CAMKK2  Pathway WP4874,0.17349814792790474,1.974656529278378,3.4587853806620767,"['FIS1', 'MAP1LC3A', 'NOS1', 'CALM2']",0.9998938720068727,0,0,4
59,Cysteine and methionine catabolism WP4504,0.1848567376231088,2.9601917188124083,4.99731912431527,"['AHCY', 'GOT1']",0.9998938720068727,0,0,2
60,Glycolysis in senescence WP5049,0.1848567376231088,2.9601917188124083,4.99731912431527,"['LDHA', 'PGK1']",0.9998938720068727,0,0,2
61,Homologous recombination WP186,0.1848567376231088,2.9601917188124083,4.99731912431527,"['POLD4', 'POLD2']",0.9998938720068727,0,0,2
62,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.19483583656958905,1.5447246792573113,2.5265485012992093,"['SHC3', 'CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9998938720068727,0,0,7
63,Myometrial relaxation and contraction pathways WP289,0.20368472773923973,1.3536749969323898,2.153943198055678,"['PKIB', 'GNG3', 'YWHAQ', 'GSTO1', 'CRH', 'CALM3', 'ADCY2', 'IGFBP6', 'NOS1', 'CALM2', 'ACTG1', 'YWHAH']",0.9998938720068727,0,0,12
64,Unfolded protein response WP4925,0.20772144941552115,2.0725746268656717,3.257169747947281,"['XBP1', 'DDIT3', 'EIF2S1']",0.9998938720068727,0,0,3
65,Imatinib and Chronic Myeloid Leukemia WP3640,0.20772144941552115,2.0725746268656717,3.257169747947281,"['SPRED2', 'GADD45A', 'KIT']",0.9998938720068727,0,0,3
66,DNA damage response WP707,0.21579761297496078,1.555285313376988,2.384896720675943,"['CCND1', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.9998938720068727,0,0,6
67,ERK Pathway in Huntington's Disease WP3853,0.21827695368045555,2.5899347623485554,3.9418563442063244,"['NTRK2', 'HRAS']",0.9998938720068727,0,0,2
68,Fatty acid transporters WP5061,0.21827695368045555,2.5899347623485554,3.9418563442063244,"['FABP3', 'FABP6']",0.9998938720068727,0,0,2
69,Osteoclast Signaling WP12,0.21827695368045555,2.5899347623485554,3.9418563442063244,"['ATP6V1G1', 'TNFRSF11B']",0.9998938720068727,0,0,2
70,Metabolic reprogramming in colon cancer WP4290,0.229808183513136,1.727357609710551,2.5400971616011865,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9998938720068727,0,0,4
71,Canonical and non-canonical Notch signaling WP3845,0.23166134139765748,1.9428638059701493,2.8413969509557715,"['RRAS', 'MFAP1', 'DLL3']",0.9998938720068727,0,0,3
72,MED and Pseudoachondroplasia genes WP4789,0.2417714070239161,5.177839851024209,7.351303360549227,['COL9A3'],0.9998938720068727,0,0,1
73,Acute viral myocarditis WP4298,0.24536158699974217,1.4809568354937859,2.0807773661014477,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX', 'NOS1']",0.9998938720068727,0,0,6
74,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.24536158699974217,1.4809568354937859,2.0807773661014477,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9998938720068727,0,0,6
75,miRNA regulation of DNA damage response WP1530,0.24536158699974217,1.4809568354937859,2.0807773661014477,"['CCND1', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.9998938720068727,0,0,6
76,Serotonin and anxiety WP3947,0.2521416542468282,2.3019571295433363,3.1715541906370275,"['POMC', 'CRH']",0.9998938720068727,0,0,2
77,Galanin receptor pathway WP4970,0.2521416542468282,2.3019571295433363,3.1715541906370275,"['POMC', 'VAMP2']",0.9998938720068727,0,0,2
78,RalA downstream regulated genes WP2290,0.2521416542468282,2.3019571295433363,3.1715541906370275,"['RAC3', 'HRAS']",0.9998938720068727,0,0,2
79,Gastric Cancer Network 2 WP2363,0.2560627825585857,1.8284130816505706,2.4909067843340456,"['RFC3', 'S100A6', 'COL9A3']",0.9998938720068727,0,0,3
80,SARS-CoV-2 mitochondrial interactions WP5038,0.2560627825585857,1.8284130816505706,2.4909067843340456,"['NDUFB9', 'IRF3', 'PHB']",0.9998938720068727,0,0,3
81,IL-18 signaling pathway WP4754,0.2682118246377481,1.2081855141517985,1.589945822616261,"['NRN1', 'TOMM40', 'IMP3', 'BAD', 'COX17', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'ITM2C']",0.9998938720068727,0,0,17
82,Proximal tubule transport WP4917,0.2746772437812608,1.4805073431241655,1.9130501915087124,"['ATP6V1G1', 'ATP6V1E1', 'SLC6A20', 'ATP6V1D', 'ATP6V1F']",0.9998938720068727,0,0,5
83,Leptin signaling pathway WP2034,0.2760048060319194,1.4133854919636024,1.8195034394318468,"['PTPN1', 'CCND1', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9998938720068727,0,0,6
84,GABA receptor Signaling WP4159,0.2807890254104652,1.726679104477612,2.1931443841772174,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9998938720068727,0,0,3
85,Glycerophospholipid Biosynthetic Pathway WP2533,0.28611332995313693,2.0715750232991614,2.5923012189489034,"['PIP5K1A', 'CDIPT']",0.9998938720068727,0,0,2
86,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.28611332995313693,2.0715750232991614,2.5923012189489034,"['BAD', 'BAX']",0.9998938720068727,0,0,2
87,Nucleotide metabolism WP404,0.28611332995313693,2.0715750232991614,2.5923012189489034,"['NME2', 'OAZ1']",0.9998938720068727,0,0,2
88,Endometrial cancer WP4155,0.2922402663844477,1.439252336448598,1.7705379783669137,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'HRAS']",0.9998938720068727,0,0,5
89,Ras signaling WP4223,0.30264636317994387,1.2198550163244979,1.457958850351696,"['NTRK2', 'GNG10', 'GNG3', 'SHC3', 'RRAS', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'PAK4']",0.9998938720068727,0,0,12
90,BDNF-TrkB Signaling WP3676,0.3057123251466653,1.63565396700707,1.9384310719601994,"['NTRK2', 'HOMER1', 'HRAS']",0.9998938720068727,0,0,3
91,Acetylcholine Synthesis WP528,0.30860435518283547,3.4515828677839853,4.058009501318977,['PDHA1'],0.9998938720068727,0,0,1
92,Aflatoxin B1 metabolism WP699,0.30860435518283547,3.4515828677839853,4.058009501318977,['AKR7A3'],0.9998938720068727,0,0,1
93,Cytosine methylation WP3585,0.30860435518283547,3.4515828677839853,4.058009501318977,['TDG'],0.9998938720068727,0,0,1
94,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.3099892090408461,1.4002273301338721,1.6399711614136272,"['TMSB4X', 'NEFL', 'NOS1', 'PFN2', 'SOD1']",0.9998938720068727,0,0,5
95,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3199104058072488,1.8830805727357451,2.146173864788933,"['RRAS', 'HRAS']",0.9998938720068727,0,0,2
96,Intraflagellar transport proteins binding to dynein WP4532,0.3199104058072488,1.8830805727357451,2.146173864788933,"['IFT22', 'DYNLL1']",0.9998938720068727,0,0,2
97,MET in type 1 papillary renal cell carcinoma WP4205,0.3309782012948176,1.4288933964390353,1.579931376316637,"['BAD', 'RPL11', 'HRAS', 'PAK4']",0.9998938720068727,0,0,4
98,Cytosolic DNA-sensing pathway WP4655,0.35167384149739433,1.3811391223155929,1.4433609860798617,"['IRF3', 'POLR3K', 'POLR2K', 'POLR2L']",0.9998938720068727,0,0,4
99,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.353300018421606,1.7260018639328985,1.795797361998718,"['CD63', 'SOD1']",0.9998938720068727,0,0,2
100,Methionine De Novo and Salvage Pathway WP3580,0.353300018421606,1.7260018639328985,1.795797361998718,"['AHCY', 'TXN']",0.9998938720068727,0,0,2
101,Bladder cancer WP2828,0.3556868009762073,1.4796108742004264,1.529480726514862,"['CCND1', 'DAPK1', 'HRAS']",0.9998938720068727,0,0,3
102,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3556868009762073,1.4796108742004264,1.529480726514862,"['STAR', 'CALM3', 'CALM2']",0.9998938720068727,0,0,3
103,The alternative pathway of fetal androgen synthesis WP4524,0.3695514004926828,2.5884543761638734,2.5767168745757454,['STAR'],0.9998938720068727,0,0,1
104,Effects of nitric oxide WP1995,0.3695514004926828,2.5884543761638734,2.5767168745757454,['NOS1'],0.9998938720068727,0,0,1
105,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.3695514004926828,2.5884543761638734,2.5767168745757454,['MAP1LC3A'],0.9998938720068727,0,0,1
106,Iron metabolism in placenta WP2007,0.3695514004926828,2.5884543761638734,2.5767168745757454,['FTH1'],0.9998938720068727,0,0,1
107,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3695514004926828,2.5884543761638734,2.5767168745757454,['MOCS2'],0.9998938720068727,0,0,1
108,Kit receptor signaling pathway WP304,0.3723739271962041,1.3364657691033404,1.320236729722393,"['BAD', 'RPS6', 'KIT', 'HRAS']",0.9998938720068727,0,0,4
109,Pathways in clear cell renal cell carcinoma WP4018,0.3773804166170373,1.2086142322097377,1.177796427715219,"['SETD2', 'LDHA', 'TPI1', 'PGBD5', 'PGK1', 'ALDOA', 'PFKM']",0.9998938720068727,0,0,7
110,Blood Clotting Cascade WP272,0.38609163028837995,1.5930891103304896,1.5161119263286842,"['F8A1', 'F11']",0.9998938720068727,0,0,2
111,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.38609163028837995,1.5930891103304896,1.5161119263286842,"['GOT1', 'SCO2']",0.9998938720068727,0,0,2
112,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.38609163028837995,1.5930891103304896,1.5161119263286842,"['LDHA', 'PDHA1']",0.9998938720068727,0,0,2
113,G Protein Signaling Pathways WP35,0.40432716222771975,1.1950780744045477,1.0821801496738248,"['GNG10', 'GNG3', 'RRAS', 'ADCY2', 'HRAS', 'CALM2']",0.9998938720068727,0,0,6
114,Statin inhibition of cholesterol production WP430,0.4181313893895076,1.4791638929569964,1.289771107869262,"['SQLE', 'APOC1']",0.9998938720068727,0,0,2
115,Urea cycle and associated pathways WP4595,0.4181313893895076,1.4791638929569964,1.289771107869262,"['GOT1', 'NOS1']",0.9998938720068727,0,0,2
116,IL-7 signaling pathway WP205,0.4181313893895076,1.4791638929569964,1.289771107869262,"['CCND1', 'BAD']",0.9998938720068727,0,0,2
117,Alanine and aspartate metabolism WP106,0.4251304659915194,2.0705772811918064,1.7710872819762775,['GOT1'],0.9998938720068727,0,0,1
118,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4251304659915194,2.0705772811918064,1.7710872819762775,['DLL3'],0.9998938720068727,0,0,1
119,Thiamine metabolic pathways WP4297,0.4251304659915194,2.0705772811918064,1.7710872819762775,['PDHA1'],0.9998938720068727,0,0,1
120,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4251304659915194,2.0705772811918064,1.7710872819762775,['VIP'],0.9998938720068727,0,0,1
121,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4251304659915194,2.0705772811918064,1.7710872819762775,['RPS6'],0.9998938720068727,0,0,1
122,Insulin signaling in adipocytes (normal condition) WP3634,0.4251304659915194,2.0705772811918064,1.7710872819762775,['RPS6'],0.9998938720068727,0,0,1
123,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4251304659915194,2.0705772811918064,1.7710872819762775,['AHCY'],0.9998938720068727,0,0,1
124,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4251304659915194,2.0705772811918064,1.7710872819762775,['VEGFB'],0.9998938720068727,0,0,1
125,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.4294861672927866,1.2943097014925373,1.0939062226210865,"['YWHAQ', 'ACTG1', 'PAK4']",0.9998938720068727,0,0,3
126,Oxidative Damage WP3941,0.4294861672927866,1.2943097014925373,1.0939062226210865,"['BAD', 'GADD45A', 'CYCS']",0.9998938720068727,0,0,3
127,Modulators of TCR signaling and T cell activation WP5072,0.43394707715845904,1.2182127753062009,1.0170038534985988,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9998938720068727,0,0,4
128,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.44929715308292983,1.3804287045666357,1.1044406969909806,"['BAD', 'HRAS']",0.9998938720068727,0,0,2
129,Pancreatic adenocarcinoma pathway WP4263,0.4526999557979734,1.1295858491368314,0.8952258408527289,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'PAK4']",0.9998938720068727,0,0,6
130,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4541301295574945,1.1832999866613312,0.9340632771729529,"['RPS6', 'ADCY2', 'HRAS', 'MYL12B']",0.9998938720068727,0,0,4
131,Folate Metabolism WP176,0.4541301295574945,1.1832999866613312,0.9340632771729529,"['AHCY', 'GPX4', 'NOS1', 'SOD1']",0.9998938720068727,0,0,4
132,Genotoxicity pathway WP4286,0.4541301295574945,1.1832999866613312,0.9340632771729529,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9998938720068727,0,0,4
133,p53 transcriptional gene network WP4963,0.4541301295574945,1.1832999866613312,0.9340632771729529,"['SIVA1', 'GADD45A', 'SESN1', 'BAX']",0.9998938720068727,0,0,4
134,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.47581394014811884,1.7253258845437616,1.2814485047320003,['HMGCS1'],0.9998938720068727,0,0,1
135,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.47581394014811884,1.7253258845437616,1.2814485047320003,['IDH3B'],0.9998938720068727,0,0,1
136,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.47581394014811884,1.7253258845437616,1.2814485047320003,['NSDHL'],0.9998938720068727,0,0,1
137,NO metabolism in cystic fibrosis WP4947,0.47581394014811884,1.7253258845437616,1.2814485047320003,['NOS1'],0.9998938720068727,0,0,1
138,NOTCH1 regulation of endothelial cell calcification WP3413,0.47581394014811884,1.7253258845437616,1.2814485047320003,['DLL3'],0.9998938720068727,0,0,1
139,Purine metabolism WP4792,0.47581394014811884,1.7253258845437616,1.2814485047320003,['APRT'],0.9998938720068727,0,0,1
140,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.4769792280600657,1.19453214695752,0.8842910482793985,"['NTRK2', 'HOMER1', 'HRAS']",0.9998938720068727,0,0,3
141,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4769792280600657,1.19453214695752,0.8842910482793985,"['ADCY2', 'BANF1', 'HRAS']",0.9998938720068727,0,0,3
142,16p11.2 proximal deletion syndrome WP4949,0.4886949499400449,1.1013123881487372,0.7885581812357345,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9998938720068727,0,0,5
143,ErbB signaling pathway WP673,0.4886949499400449,1.1013123881487372,0.7885581812357345,"['SHC3', 'CCND1', 'BAD', 'HRAS', 'PAK4']",0.9998938720068727,0,0,5
144,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.49096703082968884,1.0617835772474948,0.7553297966051663,"['NTRK2', 'RAB3A', 'SHC3', 'BAD', 'RPS6', 'RACK1', 'EIF2S1', 'HRAS']",0.9998938720068727,0,0,8
145,Glycosylation and related congenital defects WP4521,0.5086508831047217,1.217806041335453,0.8232288288502535,"['DPM2', 'DPM3']",0.9998938720068727,0,0,2
146,Serotonin and anxiety-related events WP3944,0.5220326763124823,1.4787177440808725,0.9612036417178592,['CRH'],0.9998938720068727,0,0,1
147,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.5220326763124823,1.4787177440808725,0.9612036417178592,['PDHA1'],0.9998938720068727,0,0,1
148,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5220326763124823,1.4787177440808725,0.9612036417178592,['SMAD9'],0.9998938720068727,0,0,1
149,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5220326763124823,1.4787177440808725,0.9612036417178592,['CCK'],0.9998938720068727,0,0,1
150,Dopamine metabolism WP2436,0.5220326763124823,1.4787177440808725,0.9612036417178592,['SOD1'],0.9998938720068727,0,0,1
151,Macrophage markers WP4146,0.5220326763124823,1.4787177440808725,0.9612036417178592,['CD163'],0.9998938720068727,0,0,1
152,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5220326763124823,1.4787177440808725,0.9612036417178592,['IRF3'],0.9998938720068727,0,0,1
153,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5320608505943292,1.0615528262587086,0.6698370896427317,"['PSMD8', 'PSMC5', 'PSMD7', 'STUB1']",0.9998938720068727,0,0,4
154,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.5367162115758716,1.1500465983224604,0.7156576608344007,"['MAP1LC3A', 'FTL']",0.9998938720068727,0,0,2
155,Hippo-Merlin Signaling Dysregulation WP4541,0.5378098530113473,1.0203486838634805,0.6328714898851542,"['NTRK2', 'CCND1', 'KIT', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9998938720068727,0,0,7
156,Circadian rhythm related genes WP3594,0.5428917219215376,1.0046948356807512,0.6137132047890734,"['KDM5A', 'RAI1', 'AHCY', 'HOMER1', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'HCRTR1']",0.9998938720068727,0,0,10
157,IL-3 signaling pathway WP286,0.5444986614734807,1.0706703551209469,0.650849582557923,"['YWHAQ', 'BAD', 'HRAS']",0.9998938720068727,0,0,3
158,Senescence and Autophagy in Cancer WP615,0.5460238741416814,1.017926973270561,0.6159400571427841,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9998938720068727,0,0,6
159,Cell cycle WP179,0.5516816971937307,1.0060861423220975,0.5984039748269789,"['CDKN2D', 'CCND1', 'YWHAQ', 'GADD45A', 'RBX1', 'ANAPC11', 'YWHAH']",0.9998938720068727,0,0,7
160,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['TNFRSF11B', 'PPIB']",0.9998938720068727,0,0,2
161,Fluoropyrimidine Activity WP1601,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['TDG', 'GGH']",0.9998938720068727,0,0,2
162,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['RAB3A', 'NEFL']",0.9998938720068727,0,0,2
163,MAPK Cascade WP422,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['RRAS', 'HRAS']",0.9998938720068727,0,0,2
164,Monoamine Transport WP727,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['TNFRSF11B', 'NOS1']",0.9998938720068727,0,0,2
165,Oxidative Stress WP408,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['TXN2', 'SOD1']",0.9998938720068727,0,0,2
166,Parkinson's disease pathway WP2371,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['CYCS', 'PARK7']",0.9998938720068727,0,0,2
167,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5636558983242337,1.0894197282582037,0.6245766657434798,"['BAX', 'NOS1']",0.9998938720068727,0,0,2
168,Biomarkers for urea cycle disorders WP4583,0.5641796414946102,1.2937616387337059,0.7405266051610176,['GOT1'],0.9998938720068727,0,0,1
169,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5641796414946102,1.2937616387337059,0.7405266051610176,['CCND1'],0.9998938720068727,0,0,1
170,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5641796414946102,1.2937616387337059,0.7405266051610176,['ADCY2'],0.9998938720068727,0,0,1
171,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5641796414946102,1.2937616387337059,0.7405266051610176,['BAX'],0.9998938720068727,0,0,1
172,Nanoparticle triggered autophagic cell death WP2509,0.5641796414946102,1.2937616387337059,0.7405266051610176,['MAP1LC3A'],0.9998938720068727,0,0,1
173,Nanoparticle triggered regulated necrosis WP2513,0.5641796414946102,1.2937616387337059,0.7405266051610176,['FTL'],0.9998938720068727,0,0,1
174,SARS coronavirus and innate immunity WP4912,0.5641796414946102,1.2937616387337059,0.7405266051610176,['IRF3'],0.9998938720068727,0,0,1
175,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.565850694311284,1.0348880597014924,0.5892911608690834,"['BEX3', 'SERBP1', 'RNF7']",0.9998938720068727,0,0,3
176,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.565850694311284,1.0348880597014924,0.5892911608690834,"['RRAS', 'CHP1', 'CALM2']",0.9998938720068727,0,0,3
177,White fat cell differentiation WP4149,0.5894502376949368,1.0348555452003727,0.546988397442395,"['IRF3', 'DDIT3']",0.9998938720068727,0,0,2
178,Rett syndrome causing genes WP4312,0.5894502376949368,1.0348555452003727,0.546988397442395,"['EIF2B2', 'GPS2']",0.9998938720068727,0,0,2
179,Serotonin Transporter Activity WP1455,0.6026132448381042,1.1499068901303537,0.5824044657416726,['NOS1'],0.9998938720068727,0,0,1
180,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6026132448381042,1.1499068901303537,0.5824044657416726,['STAR'],0.9998938720068727,0,0,1
181,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.6026132448381042,1.1499068901303537,0.5824044657416726,['CCND1'],0.9998938720068727,0,0,1
182,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.6026132448381042,1.1499068901303537,0.5824044657416726,['RRAS'],0.9998938720068727,0,0,1
183,PPAR-alpha pathway WP2878,0.6026132448381042,1.1499068901303537,0.5824044657416726,['CCND1'],0.9998938720068727,0,0,1
184,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6026132448381042,1.1499068901303537,0.5824044657416726,['ANAPC11'],0.9998938720068727,0,0,1
185,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6040689019214533,0.9624563003495972,0.48514247104024544,"['BAD', 'BAX', 'NOS1', 'HRAS']",0.9998938720068727,0,0,4
186,Notch Signaling Pathway Netpath WP61,0.6066590407337207,0.9700326492537313,0.48481102485813504,"['PSENEN', 'CCND1', 'DLL3']",0.9998938720068727,0,0,3
187,Vitamin D-sensitive calcium signaling in depression WP4698,0.6140917247617995,0.9854879510051924,0.4805347387970723,"['GPX4', 'PVALB']",0.9998938720068727,0,0,2
188,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6140917247617995,0.9854879510051924,0.4805347387970723,"['MAP1LC3A', 'EIF2B2']",0.9998938720068727,0,0,2
189,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6140917247617995,0.9854879510051924,0.4805347387970723,"['CYCS', 'ACTG1']",0.9998938720068727,0,0,2
190,IL-2 signaling pathway WP49,0.6140917247617995,0.9854879510051924,0.4805347387970723,"['RPS6', 'HRAS']",0.9998938720068727,0,0,2
191,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6140917247617995,0.9854879510051924,0.4805347387970723,"['PTPN1', 'CCND1']",0.9998938720068727,0,0,2
192,Apoptosis Modulation and Signaling WP1772,0.6179677358416706,0.9403860872523174,0.4526257195893245,"['ENDOG', 'AIFM2', 'BAD', 'CYCS', 'BAX', 'TNFRSF11B']",0.9998938720068727,0,0,6
193,G1 to S cell cycle control WP45,0.6209839075122049,0.9404974110856463,0.44810009610767565,"['CDKN2D', 'CCND1', 'GADD45A', 'RPA2']",0.9998938720068727,0,0,4
194,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.6260806472000906,0.9405529172320217,0.44043843949724126,"['IDI1', 'SQLE', 'HMGCS1']",0.9998938720068727,0,0,3
195,Exercise-induced Circadian Regulation WP410,0.6260806472000906,0.9405529172320217,0.44043843949724126,"['IDI1', 'SUMO1', 'STBD1']",0.9998938720068727,0,0,3
196,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.6305711858582521,0.9296252224550614,0.42867735942230867,"['NTRK2', 'YWHAQ', 'TAC1', 'ALDOA', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9998938720068727,0,0,8
197,Integrated breast cancer pathway WP1984,0.630703225092189,0.9281907231345433,0.4278215305616859,"['CCND1', 'RRAS', 'GADD45A', 'BAD', 'BAX', 'PHB', 'FAU']",0.9998938720068727,0,0,7
198,Aryl Hydrocarbon Receptor Pathway WP2873,0.6375830619607172,0.9406083199186648,0.42334026111741657,"['AIP', 'BAX']",0.9998938720068727,0,0,2
199,Glycogen Synthesis and Degradation WP500,0.6375830619607172,0.9406083199186648,0.42334026111741657,"['CALM3', 'CALM2']",0.9998938720068727,0,0,2
200,miRNA regulation of prostate cancer signaling pathways WP3981,0.6375830619607172,0.9406083199186648,0.42334026111741657,"['CCND1', 'BAD']",0.9998938720068727,0,0,2
201,p38 MAPK Signaling Pathway WP400,0.6375830619607172,0.9406083199186648,0.42334026111741657,"['DDIT3', 'HRAS']",0.9998938720068727,0,0,2
202,PDGF Pathway WP2526,0.6375830619607172,0.9406083199186648,0.42334026111741657,"['ARFIP2', 'HRAS']",0.9998938720068727,0,0,2
203,Transcriptional cascade regulating adipogenesis WP4211,0.637660374145135,1.0348230912476724,0.4656180976226482,['DDIT3'],0.9998938720068727,0,0,1
204,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.637660374145135,1.0348230912476724,0.4656180976226482,['CCND1'],0.9998938720068727,0,0,1
205,Genes targeted by miRNAs in adipocytes WP1992,0.637660374145135,1.0348230912476724,0.4656180976226482,['TMSB4X'],0.9998938720068727,0,0,1
206,Hedgehog Signaling Pathway Netpath WP47,0.637660374145135,1.0348230912476724,0.4656180976226482,['SAP18'],0.9998938720068727,0,0,1
207,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.637660374145135,1.0348230912476724,0.4656180976226482,['CCND1'],0.9998938720068727,0,0,1
208,Osteoblast Signaling WP322,0.637660374145135,1.0348230912476724,0.4656180976226482,['TNFRSF11B'],0.9998938720068727,0,0,1
209,Overview of nanoparticle effects WP3287,0.637660374145135,1.0348230912476724,0.4656180976226482,['BAX'],0.9998938720068727,0,0,1
210,Purine metabolism and related disorders WP4224,0.637660374145135,1.0348230912476724,0.4656180976226482,['APRT'],0.9998938720068727,0,0,1
211,Head and Neck Squamous Cell Carcinoma WP4674,0.6534168088858455,0.8994438355052166,0.3827493791264911,"['CCND1', 'SESN1', 'RPS6', 'HRAS']",0.9998938720068727,0,0,4
212,Endothelin Pathways WP2197,0.659935420881299,0.8996312654483569,0.37389871532638164,"['RIIAD1', 'CALM2']",0.9998938720068727,0,0,2
213,Histone Modifications WP2369,0.659935420881299,0.8996312654483569,0.37389871532638164,"['SETD2', 'SET']",0.9998938720068727,0,0,2
214,22q11.2 copy number variation syndrome WP4657,0.6621168476596355,0.8915565581695134,0.3676005656369431,"['RANBP1', 'MRPL40', 'RAN', 'RBX1', 'PAK4']",0.9998938720068727,0,0,5
215,Prader-Willi and Angelman Syndrome WP3998,0.6629081206780605,0.8866471215351812,0.3645173711874265,"['POMC', 'CCND1', 'FEZ1']",0.9998938720068727,0,0,3
216,15q13.3 copy number variation syndrome WP4942,0.6696191657341165,0.9406636194345691,0.37724951131276646,['TRPM1'],0.9998938720068727,0,0,1
217,Apoptosis Modulation by HSP70 WP384,0.6696191657341165,0.9406636194345691,0.37724951131276646,['CYCS'],0.9998938720068727,0,0,1
218,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6696191657341165,0.9406636194345691,0.37724951131276646,['CCND1'],0.9998938720068727,0,0,1
219,Glutathione metabolism WP100,0.6696191657341165,0.9406636194345691,0.37724951131276646,['GPX4'],0.9998938720068727,0,0,1
220,Glycerolipids and Glycerophospholipids WP4722,0.6696191657341165,0.9406636194345691,0.37724951131276646,['CDIPT'],0.9998938720068727,0,0,1
221,Integrin-mediated Cell Adhesion WP185,0.6758453785124708,0.8763662284175511,0.34335236516596296,"['SHC3', 'RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9998938720068727,0,0,5
222,Common Pathways Underlying Drug Addiction WP2636,0.6811669316071373,0.8620689655172413,0.3309895480129045,"['CALM2', 'ACTG1']",0.9998938720068727,0,0,2
223,Thermogenesis WP4321,0.6839373074906762,0.861811391223156,0.32739268593594006,"['RPS6', 'ADCY2', 'HRAS', 'ACTG1']",0.9998938720068727,0,0,4
224,Small cell lung cancer WP4658,0.6891979342464586,0.8616822429906542,0.32074119949974866,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'CKS1B']",0.9998938720068727,0,0,5
225,Regulation of Actin Cytoskeleton WP51,0.6901111264760273,0.871880781553179,0.32338288494648915,"['RRAS', 'TMSB4X', 'PIP5K1A', 'BRK1', 'RAC3', 'ACTG1', 'PAK4']",0.9998938720068727,0,0,7
226,Pathogenic Escherichia coli infection WP2272,0.697028167738118,0.8385689794271883,0.30266424574299544,"['YWHAQ', 'ARPC5L', 'ACTG1']",0.9998938720068727,0,0,3
227,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.69847018036713,0.8441471826825968,0.30293301496518893,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9998938720068727,0,0,4
228,Airway smooth muscle cell contraction WP4962,0.6987615310913322,0.8621973929236499,0.309050993045105,['CALM2'],0.9998938720068727,0,0,1
229,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6987615310913322,0.8621973929236499,0.309050993045105,['NOS1'],0.9998938720068727,0,0,1
230,miRNAs involved in DNA damage response WP1545,0.6987615310913322,0.8621973929236499,0.309050993045105,['CCND1'],0.9998938720068727,0,0,1
231,MTHFR deficiency WP4288,0.6987615310913322,0.8621973929236499,0.309050993045105,['CYCS'],0.9998938720068727,0,0,1
232,Nicotine Activity on Dopaminergic Neurons WP1602,0.6987615310913322,0.8621973929236499,0.309050993045105,['ADCY2'],0.9998938720068727,0,0,1
233,Cardiac Progenitor Differentiation WP2406,0.7013013714919418,0.8275116495806151,0.2936156708294404,"['MESP1', 'KIT']",0.9998938720068727,0,0,2
234,Interleukin-11 Signaling Pathway WP2332,0.7013013714919418,0.8275116495806151,0.2936156708294404,"['RPS6', 'HRAS']",0.9998938720068727,0,0,2
235,Complement system WP2806,0.7021714017564918,0.8474796997089015,0.2996499592179464,"['RPS19', 'F11', 'CD59', 'TXN', 'CALR']",0.9998938720068727,0,0,5
236,Retinoblastoma gene in cancer WP2446,0.7125166688541233,0.8271895424836602,0.28037752683287404,"['RFC3', 'CCND1', 'H2AFZ', 'RPA2']",0.9998938720068727,0,0,4
237,Phosphoinositides metabolism WP4971,0.7203670309381662,0.795612588716037,0.26095649886245026,"['PIP4P1', 'PIP5K1A']",0.9998938720068727,0,0,2
238,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7253354617321527,0.7958028935682567,0.2555490411236001,['HRAS'],0.9998938720068727,0,0,1
239,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7253354617321527,0.7958028935682567,0.2555490411236001,['IRF3'],0.9998938720068727,0,0,1
240,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7253354617321527,0.7958028935682567,0.2555490411236001,['CALM2'],0.9998938720068727,0,0,1
241,Hippo-Yap signaling pathway WP4537,0.7253354617321527,0.7958028935682567,0.2555490411236001,['YWHAQ'],0.9998938720068727,0,0,1
242,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7253354617321527,0.7958028935682567,0.2555490411236001,['BAX'],0.9998938720068727,0,0,1
243,Calcium Regulation in the Cardiac Cell WP536,0.736885397837786,0.8349663457442277,0.2549343436375092,"['PKIB', 'GNG3', 'YWHAQ', 'CALM3', 'ADCY2', 'CALR', 'CALM2', 'YWHAH']",0.9998938720068727,0,0,8
244,Aryl Hydrocarbon Receptor Netpath WP2586,0.7383957349281561,0.766076421248835,0.2323321115654464,"['AIP', 'HRAS']",0.9998938720068727,0,0,2
245,IL-6 signaling pathway WP364,0.7383957349281561,0.766076421248835,0.2323321115654464,"['BAD', 'VIP']",0.9998938720068727,0,0,2
246,Integrated Cancer Pathway WP1971,0.7383957349281561,0.766076421248835,0.2323321115654464,"['BAD', 'BAX']",0.9998938720068727,0,0,2
247,Neovascularisation processes WP4331,0.7383957349281561,0.766076421248835,0.2323321115654464,"['KIT', 'SMAD9']",0.9998938720068727,0,0,2
248,Neural Crest Cell Migration in Cancer WP4565,0.7383957349281561,0.766076421248835,0.2323321115654464,"['NTRK2', 'PAK4']",0.9998938720068727,0,0,2
249,Prolactin Signaling Pathway WP2037,0.7391564721781153,0.7952309128779717,0.24035508052780244,"['PTPN1', 'RPS6', 'PPIB', 'HRAS']",0.9998938720068727,0,0,4
250,TGF-beta Signaling Pathway WP366,0.7403633671086451,0.815912559696716,0.24527488236765804,"['PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'RBX1']",0.9998938720068727,0,0,6
251,Fatty acid beta-oxidation WP143,0.7495671316490046,0.7388933226922054,0.2129929435525837,['TPI1'],0.9998938720068727,0,0,1
252,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7495671316490046,0.7388933226922054,0.2129929435525837,['H2AFZ'],0.9998938720068727,0,0,1
253,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7495671316490046,0.7388933226922054,0.2129929435525837,['RPS6'],0.9998938720068727,0,0,1
254,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7554220015636915,0.7386499800292904,0.20717561822198619,"['STAR', 'HRAS']",0.9998938720068727,0,0,2
255,One-carbon metabolism and related pathways WP3940,0.7554220015636915,0.7386499800292904,0.20717561822198619,"['GPX4', 'SOD1']",0.9998938720068727,0,0,2
256,Amino Acid metabolism WP3925,0.7572802893098275,0.7564843465598835,0.21031916299164488,"['LDHA', 'PDHA1', 'GOT1']",0.9998938720068727,0,0,3
257,Apoptosis WP254,0.7638834889275365,0.765639589169001,0.20621736912799862,"['IRF3', 'BAD', 'CYCS', 'BAX']",0.9998938720068727,0,0,4
258,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7714823213893928,0.7131150175145419,0.18501164553155505,"['CCND1', 'BAX']",0.9998938720068727,0,0,2
259,PPAR signaling pathway WP3942,0.7714823213893928,0.7131150175145419,0.18501164553155505,"['FABP3', 'FABP6']",0.9998938720068727,0,0,2
260,NRF2-ARE regulation WP4357,0.7716628151706119,0.6895716945996275,0.17874221866296322,['RBX1'],0.9998938720068727,0,0,1
261,PDGFR-beta pathway WP3972,0.7716628151706119,0.6895716945996275,0.17874221866296322,['HRAS'],0.9998938720068727,0,0,1
262,Physiological and pathological hypertrophy of the heart WP1528,0.7716628151706119,0.6895716945996275,0.17874221866296322,['CALM2'],0.9998938720068727,0,0,1
263,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7716628151706119,0.6895716945996275,0.17874221866296322,['BAX'],0.9998938720068727,0,0,1
264,TNF-alpha signaling pathway WP231,0.7755437820555849,0.7516509634156693,0.19106279083560335,"['BAD', 'BAX', 'TXN', 'HRAS']",0.9998938720068727,0,0,4
265,Breast cancer pathway WP4262,0.7804788454533077,0.7859469141833577,0.19479509038692264,"['SHC3', 'CCND1', 'GADD45A', 'KIT', 'BAX', 'HRAS', 'DLL3']",0.9998938720068727,0,0,7
266,DNA damage response (only ATM dependent) WP710,0.7823539451203751,0.759758108851017,0.18648112774557257,"['CCND1', 'BAD', 'RAC3', 'BAX', 'HRAS']",0.9998938720068727,0,0,5
267,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7866145422840527,0.68928238583411,0.16543944327745666,"['NDUFA13', 'COPS6']",0.9998938720068727,0,0,2
268,Insulin Signaling WP481,0.7891854738767005,0.7774253956747614,0.18405850304559707,"['PTPN1', 'XBP1', 'SHC3', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9998938720068727,0,0,7
269,Striated Muscle Contraction Pathway WP383,0.7918106361388739,0.646415270018622,0.15089466318583442,['ACTG1'],0.9998938720068727,0,0,1
270,Autophagy WP4923,0.7918106361388739,0.646415270018622,0.15089466318583442,['MAP1LC3B'],0.9998938720068727,0,0,1
271,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.7918106361388739,0.646415270018622,0.15089466318583442,['IRF3'],0.9998938720068727,0,0,1
272,Differentiation of white and brown adipocyte WP2895,0.7918106361388739,0.646415270018622,0.15089466318583442,['SMAD9'],0.9998938720068727,0,0,1
273,Nanoparticle-mediated activation of receptor signaling WP2643,0.7918106361388739,0.646415270018622,0.15089466318583442,['HRAS'],0.9998938720068727,0,0,1
274,Pregnane X receptor pathway WP2876,0.7918106361388739,0.646415270018622,0.15089466318583442,['PSMC5'],0.9998938720068727,0,0,1
275,Interferon type I signaling pathways WP585,0.8008573479232908,0.666987343294351,0.14811950694418433,"['RPS6', 'RACK1']",0.9998938720068727,0,0,2
276,Gastrin signaling pathway WP4659,0.8019194739477518,0.7379172229639519,0.16289307424753635,"['CCND1', 'BAD', 'RPS6', 'KIT', 'HRAS']",0.9998938720068727,0,0,5
277,Hepatitis B infection WP4666,0.8075654654798881,0.7466272949609476,0.15957751438259252,"['YWHAQ', 'IRF3', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9998938720068727,0,0,6
278,TLR4 Signaling and Tolerance WP3851,0.810182163766056,0.6083360718589111,0.1280524089785542,['IRF3'],0.9998938720068727,0,0,1
279,Ethanol effects on histone modifications WP3996,0.810182163766056,0.6083360718589111,0.1280524089785542,['AHCY'],0.9998938720068727,0,0,1
280,RAS and bradykinin pathways in COVID-19 WP4969,0.810182163766056,0.6083360718589111,0.1280524089785542,['NOS1'],0.9998938720068727,0,0,1
281,"Relationship between inflammation, COX-2 and EGFR WP4483",0.810182163766056,0.6083360718589111,0.1280524089785542,['HRAS'],0.9998938720068727,0,0,1
282,Phosphodiesterases in neuronal function WP4222,0.8142498166426719,0.6460857409133272,0.13276290550128314,"['ADCY2', 'NOS1']",0.9998938720068727,0,0,2
283,Focal Adhesion WP306,0.8264875324961746,0.7613723741272722,0.145095073316053,"['SHC3', 'CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9998938720068727,0,0,9
284,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8269338682766113,0.574487895716946,0.10917025249426786,['HRAS'],0.9998938720068727,0,0,1
285,Trans-sulfuration and one-carbon metabolism WP2525,0.8269338682766113,0.574487895716946,0.10917025249426786,['AHCY'],0.9998938720068727,0,0,1
286,One-carbon metabolism WP241,0.8269338682766113,0.574487895716946,0.10917025249426786,['AHCY'],0.9998938720068727,0,0,1
287,TGF-beta Receptor Signaling WP560,0.8386398758058466,0.6079710542185187,0.10698703441418006,"['SMAD9', 'HRAS']",0.9998938720068727,0,0,2
288,7-oxo-C and 7beta-HC pathways WP5064,0.8422084484092752,0.5442026854846613,0.0934546928978219,['THEM5'],0.9998938720068727,0,0,1
289,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8422084484092752,0.5442026854846613,0.0934546928978219,['IRF3'],0.9998938720068727,0,0,1
290,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8422084484092752,0.5442026854846613,0.0934546928978219,['SUPT4H1'],0.9998938720068727,0,0,1
291,Lipid Metabolism Pathway WP3965,0.8422084484092752,0.5442026854846613,0.0934546928978219,['PDHA1'],0.9998938720068727,0,0,1
292,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8422084484092752,0.5442026854846613,0.0934546928978219,['OMG'],0.9998938720068727,0,0,1
293,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8497145727129165,0.5905471974437492,0.09617343551289889,"['IRF3', 'PIN1']",0.9998938720068727,0,0,2
294,Target Of Rapamycin (TOR) Signaling WP1471,0.8561360424926472,0.5169459962756052,0.08029514726393155,['IDI1'],0.9998938720068727,0,0,1
295,The influence of laminopathies on Wnt signaling WP4844,0.8561360424926472,0.5169459962756052,0.08029514726393155,['CCND1'],0.9998938720068727,0,0,1
296,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8561360424926472,0.5169459962756052,0.08029514726393155,['DDIT3'],0.9998938720068727,0,0,1
297,Melatonin metabolism and effects WP3298,0.8561360424926472,0.5169459962756052,0.08029514726393155,['CALM2'],0.9998938720068727,0,0,1
298,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8561360424926472,0.5169459962756052,0.08029514726393155,['CCND1'],0.9998938720068727,0,0,1
299,3q29 copy number variation syndrome WP4906,0.8600926850694278,0.5740913327120224,0.08652424536662048,"['NCBP2', 'DYNLL1']",0.9998938720068727,0,0,2
300,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8688353332010387,0.49228518222931633,0.06921611463181045,['HRAS'],0.9998938720068727,0,0,1
301,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8688353332010387,0.49228518222931633,0.06921611463181045,['NTRK2'],0.9998938720068727,0,0,1
302,Prion disease pathway WP3995,0.8688353332010387,0.49228518222931633,0.06921611463181045,['HSP90B1'],0.9998938720068727,0,0,1
303,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8698108457747981,0.5585249741820105,0.0779027895105616,"['SMAD9', 'HRAS']",0.9998938720068727,0,0,2
304,Pathways affected in adenoid cystic carcinoma WP3651,0.8698108457747981,0.5585249741820105,0.0779027895105616,"['SETD2', 'HRAS']",0.9998938720068727,0,0,2
305,Corticotropin-releasing hormone signaling pathway WP2355,0.8742370103448499,0.5958668197474167,0.08008674175112487,"['POMC', 'STAR', 'CRH']",0.9998938720068727,0,0,3
306,Fragile X Syndrome  WP4549,0.8756512387136188,0.6257533316356846,0.08309215584834789,"['NTRK2', 'HOMER1', 'AP2S1', 'AP2M1']",0.9998938720068727,0,0,4
307,Cell migration and invasion through p75NTR WP4561,0.8804145547722252,0.46986626036905366,0.05984329340951992,['NTRK2'],0.9998938720068727,0,0,1
308,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8804145547722252,0.46986626036905366,0.05984329340951992,['CCND1'],0.9998938720068727,0,0,1
309,Disruption of postsynaptic signaling by CNV WP4875,0.8909724125901001,0.44939680997490083,0.05187918308024446,['HOMER1'],0.9998938720068727,0,0,1
310,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8909724125901001,0.44939680997490083,0.05187918308024446,['YWHAQ'],0.9998938720068727,0,0,1
311,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8953557562406906,0.5164958061509786,0.057090423196872714,"['HMGCS1', 'CALM2']",0.9998938720068727,0,0,2
312,Endochondral Ossification WP474,0.8953557562406906,0.5164958061509786,0.057090423196872714,"['HMGCS1', 'CALM2']",0.9998938720068727,0,0,2
313,Oncostatin M Signaling Pathway WP2374,0.8953557562406906,0.5164958061509786,0.057090423196872714,"['RPS6', 'HRAS']",0.9998938720068727,0,0,2
314,Chemokine signaling pathway WP3929,0.897182473107115,0.6216079270352438,0.06744198087979394,"['GNG10', 'GNG3', 'SHC3', 'ADCY2', 'HRAS']",0.9998938720068727,0,0,5
315,ATM Signaling Pathway WP2516,0.9005989208804538,0.430633147113594,0.04508525332305163,['GADD45A'],0.9998938720068727,0,0,1
316,Toll-like Receptor Signaling related to MyD88 WP3858,0.9005989208804538,0.430633147113594,0.04508525332305163,['IRF3'],0.9998938720068727,0,0,1
317,Heart Development WP1591,0.9005989208804538,0.430633147113594,0.04508525332305163,['VEGFB'],0.9998938720068727,0,0,1
318,IL-5 signaling pathway WP127,0.9005989208804538,0.430633147113594,0.04508525332305163,['RPS6'],0.9998938720068727,0,0,1
319,Differentiation Pathway WP2848,0.9093761676673243,0.4133705772811918,0.0392687351399562,['KIT'],0.9998938720068727,0,0,1
320,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9093761676673243,0.4133705772811918,0.0392687351399562,['IRF3'],0.9998938720068727,0,0,1
321,G13 Signaling Pathway WP524,0.9093761676673243,0.4133705772811918,0.0392687351399562,['CALM2'],0.9998938720068727,0,0,1
322,Hedgehog Signaling Pathway WP4249,0.9093761676673243,0.4133705772811918,0.0392687351399562,['CCND1'],0.9998938720068727,0,0,1
323,AGE/RAGE pathway WP2324,0.9161704455144493,0.48033117319404406,0.042054365908723086,"['CYCS', 'SOD1']",0.9998938720068727,0,0,2
324,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9161704455144493,0.48033117319404406,0.042054365908723086,"['IFI27L2', 'HRAS']",0.9998938720068727,0,0,2
325,Mesodermal commitment pathway WP2857,0.9170986143553013,0.5928134063809217,0.05130223362109817,"['EPB41L5', 'SETD2', 'CCND1', 'SESN1', 'RPL38']",0.9998938720068727,0,0,5
326,Alpha 6 Beta 4 signaling pathway WP244,0.9173790118963081,0.3974358974358974,0.03427271566206057,['HRAS'],0.9998938720068727,0,0,1
327,Neural Crest Cell Migration during Development WP4564,0.9173790118963081,0.3974358974358974,0.03427271566206057,['PAK4'],0.9998938720068727,0,0,1
328,Regulation of Microtubule Cytoskeleton WP2038,0.9173790118963081,0.3974358974358974,0.03427271566206057,['PARD6A'],0.9998938720068727,0,0,1
329,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9237324631887378,0.6863593603010348,0.054450803866535016,"['GNG10', 'GNG3', 'RAB14', 'CAB39L', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'ITGAE', 'NOS1', 'HRAS', 'HSP90B1']",0.9998938720068727,0,0,12
330,Oxysterols derived from cholesterol WP4545,0.9246757196503786,0.38268156424581007,0.02996862612056533,['THEM5'],0.9998938720068727,0,0,1
331,Endoderm differentiation WP2853,0.9262504993863818,0.5502147525676937,0.04215226208803215,"['EPB41L5', 'SESN1', 'TCEAL2', 'NME1']",0.9998938720068727,0,0,4
332,DNA IR-damage and cellular response via ATR WP4016,0.9278144668482508,0.4589002795899348,0.03438241241303439,"['RPA2', 'EEF1E1']",0.9998938720068727,0,0,2
333,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9373942555003795,0.3562255185256534,0.02303045057181218,['CCND1'],0.9998938720068727,0,0,1
334,Microglia Pathogen Phagocytosis Pathway WP3937,0.9373942555003795,0.3562255185256534,0.02303045057181218,['RAC3'],0.9998938720068727,0,0,1
335,Spinal Cord Injury WP2431,0.9384483268764413,0.5289089994972348,0.03360025786548271,"['CCND1', 'GADD45A', 'OMG', 'NOS1']",0.9998938720068727,0,0,4
336,EGF/EGFR signaling pathway WP437,0.9406042005135689,0.5542659029243292,0.03393927740211749,"['NDUFA13', 'AP2S1', 'NEDD8', 'HRAS', 'AP2M1']",0.9998938720068727,0,0,5
337,Development of ureteric collection system WP5053,0.942924622075647,0.34432029795158287,0.020235336767304643,['CCND1'],0.9998938720068727,0,0,1
338,DNA IR-double strand breaks and cellular response via ATM WP3959,0.942924622075647,0.34432029795158287,0.020235336767304643,['BAX'],0.9998938720068727,0,0,1
339,Notch Signaling WP268,0.942924622075647,0.34432029795158287,0.020235336767304643,['DLL3'],0.9998938720068727,0,0,1
340,Prostaglandin Synthesis and Regulation WP98,0.942924622075647,0.34432029795158287,0.020235336767304643,['S100A6'],0.9998938720068727,0,0,1
341,Glioblastoma signaling pathways WP2261,0.9466707050274803,0.42128687448884494,0.02308819349628902,"['CCND1', 'HRAS']",0.9998938720068727,0,0,2
342,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9479668517775789,0.3331831561242266,0.017803889775061567,['RPS6'],0.9998938720068727,0,0,1
343,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9479668517775789,0.3331831561242266,0.017803889775061567,['RPS6'],0.9998938720068727,0,0,1
344,Vitamin B12 metabolism WP1533,0.9479668517775789,0.3331831561242266,0.017803889775061567,['SOD1'],0.9998938720068727,0,0,1
345,Wnt Signaling Pathway WP363,0.9479668517775789,0.3331831561242266,0.017803889775061567,['CCND1'],0.9998938720068727,0,0,1
346,Ectoderm Differentiation WP2858,0.9487831910738022,0.509181450357921,0.026770197888587952,"['MAFB', 'KCNK10', 'TNFRSF11B', 'LY6E']",0.9998938720068727,0,0,4
347,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.952563993330829,0.3227420856610801,0.015684616534952067,['TNFRSF11B'],0.9998938720068727,0,0,1
348,Pre-implantation embryo WP3527,0.952563993330829,0.3227420856610801,0.015684616534952067,['DDIT3'],0.9998938720068727,0,0,1
349,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.952563993330829,0.3227420856610801,0.015684616534952067,['IRF3'],0.9998938720068727,0,0,1
350,Vitamin D Receptor Pathway WP2877,0.9527492480669092,0.531216880238944,0.025712771377040873,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6', 'TNFRSF11B']",0.9998938720068727,0,0,5
351,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9559810783099962,0.45500438981562774,0.020483004820693068,"['PTPN1', 'SHC3', 'HRAS']",0.9998938720068727,0,0,3
352,Cardiac Hypertrophic Response WP2795,0.964060450206089,0.2949986698590051,0.010797328518355255,['CALM2'],0.9998938720068727,0,0,1
353,IL-4 signaling pathway WP395,0.964060450206089,0.2949986698590051,0.010797328518355255,['BAD'],0.9998938720068727,0,0,1
354,Netrin-UNC5B signaling pathway WP4747,0.964060450206089,0.2949986698590051,0.010797328518355255,['DAPK1'],0.9998938720068727,0,0,1
355,NRF2 pathway WP2884,0.9690486704771644,0.463076616414356,0.014559332954482019,"['FTH1', 'TXN', 'SLC6A20', 'FTL']",0.9998938720068727,0,0,4
356,Ebola Virus Pathway on Host WP4217,0.9747451786666343,0.40681461115475254,0.010405991226529765,"['IRF3', 'EIF2S1', 'ACTG1']",0.9998938720068727,0,0,3
357,Peptide GPCRs WP24,0.9751793056903962,0.264646898725111,0.006651614409591883,['HCRTR1'],0.9998938720068727,0,0,1
358,B Cell Receptor Signaling Pathway WP23,0.975430142519007,0.34956639866049566,0.008696070125208894,"['PIP5K1A', 'HRAS']",0.9998938720068727,0,0,2
359,Adipogenesis WP236,0.9764674501877154,0.401494960263617,0.009561145722780679,"['GADD45A', 'DDIT3', 'GTF3A']",0.9998938720068727,0,0,3
360,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9773735477955786,0.2580074487895717,0.005904850932466762,['YWHAQ'],0.9998938720068727,0,0,1
361,Genes related to primary cilium development (based on CRISPR) WP4536,0.9790134006728276,0.3380440927077445,0.007169897770655444,"['TRAF3IP1', 'DYNLL1']",0.9998938720068727,0,0,2
362,RANKL/RANK signaling pathway WP2018,0.9793739552092553,0.25169187446064406,0.0052456947616574285,['TNFRSF11B'],0.9998938720068727,0,0,1
363,PI3K-Akt signaling pathway WP4172,0.9806084077871459,0.5704887218045113,0.011171353323015632,"['NTRK2', 'GNG10', 'GNG3', 'CCND1', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS', 'HSP90B1']",0.9998938720068727,0,0,11
364,MECP2 and Associated Rett Syndrome WP3584,0.98119763614947,0.24567704176642724,0.004663288241224796,['RPS6'],0.9998938720068727,0,0,1
365,Metapathway biotransformation Phase I and II WP702,0.985741060549616,0.3678038379530917,0.005282242383668168,"['AKR7A3', 'GPX4', 'GSTO1']",0.9998938720068727,0,0,3
366,Wnt signaling WP428,0.985895385138442,0.3122934847072778,0.004436138404578864,"['CCND1', 'PRICKLE2']",0.9998938720068727,0,0,2
367,Pathways Regulating Hippo Signaling WP4540,0.985895385138442,0.3122934847072778,0.004436138404578864,"['NTRK2', 'KIT']",0.9998938720068727,0,0,2
368,ESC Pluripotency Pathways WP3931,0.9889104644272231,0.2986344665505085,0.003330217139927433,"['SMAD9', 'HRAS']",0.9998938720068727,0,0,2
369,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9893417784046754,0.35095827679782904,0.0037606678919668846,"['STRAP', 'HRAS', 'DLL3']",0.9998938720068727,0,0,3
370,Male infertility WP4673,0.9897680480293705,0.29434163227266674,0.0030272030892164272,"['PEX10', 'NOS1']",0.9998938720068727,0,0,2
371,Osteoblast differentiation WP4787,0.9897680480293705,0.29434163227266674,0.0030272030892164272,"['SMAD9', 'DLL3']",0.9998938720068727,0,0,2
372,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9901664853732405,0.21044730741458595,0.002079678792851524,['ACTG1'],0.9998938720068727,0,0,1
373,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9910363782586724,0.20621973929236498,0.0018568100986864561,['CALM2'],0.9998938720068727,0,0,1
374,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9910363782586724,0.20621973929236498,0.0018568100986864561,['CCND1'],0.9998938720068727,0,0,1
375,Neural Crest Differentiation WP2064,0.9910363782586724,0.20621973929236498,0.0018568100986864561,['DLL3'],0.9998938720068727,0,0,1
376,T-cell receptor (TCR) signaling pathway WP69,0.9918293624737989,0.20215795815532916,0.0016585443462933873,['HRAS'],0.9998938720068727,0,0,1
377,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9938118551572045,0.1908752327746741,0.0011848333401335393,['CCND1'],0.9998938720068727,0,0,1
378,Toll-like Receptor Signaling Pathway WP75,0.9948585257513398,0.18402500665070498,0.0009486005304622277,['IRF3'],0.9998938720068727,0,0,1
379,Regulation of toll-like receptor signaling pathway WP1449,0.995817955031237,0.2541161851506679,0.0010649537111251976,"['CUEDC2', 'IRF3']",0.9998938720068727,0,0,2
380,Nuclear Receptors Meta-Pathway WP2882,0.9963955222453913,0.44091060253348247,0.0015921235724902357,"['PSMC5', 'CCND1', 'FTH1', 'AIP', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.9998938720068727,0,0,8
381,MAPK Signaling Pathway WP382,0.9965239648451635,0.397199674100003,0.0013830852521972566,"['NTRK2', 'RRAS', 'GADD45A', 'DDIT3', 'RAC3', 'HRAS']",0.9998938720068727,0,0,6
382,Wnt signaling pathway and pluripotency WP399,0.9967649210150796,0.16886467014683884,0.0005471761026331114,['CCND1'],0.9998938720068727,0,0,1
383,"GPCRs, Class A Rhodopsin-like WP455",0.9993609057315793,0.24624626865671642,0.00015742488895055507,"['GPR22', 'OR6A2', 'HCRTR1']",0.9998938720068727,0,0,3
384,Ciliopathies WP4803,0.9998938720068727,0.1640111835973905,1.7407101472329204e-05,"['TRAF3IP1', 'CCDC28B']",0.9998938720068727,0,0,2
